Patient Decision Aid for Chemotherapy or Exclusion in Cisplatin-Intolerant Patients With Locally Advanced Cervical Cancer: Development, Alpha Testing, and Peer Validation

PURPOSE: In locally advanced cervical cancer (LACC), adding cisplatin to radiotherapy (RT) improves survival but increases toxicity. Among patients with cisplatin contraindications, RT compliance may be compromised by toxicity because of cisplatin or a substitute. In shared decision making, a patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Bacorro, Warren, Baldivia, Kathleen, Mariano, Jocelyn, Dancel, Evelyn, Antonio, Linda, Gonzalez, Gil, Ortin, Teresa Sy, Canlas, Rodel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581640/
https://www.ncbi.nlm.nih.gov/pubmed/37677124
http://dx.doi.org/10.1200/GO.23.00096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581640/
https://www.ncbi.nlm.nih.gov/pubmed/37677124
http://dx.doi.org/10.1200/GO.23.00096

Ejemplares similares